Press Releases
Q1FY26 Results
GlaxoSmithKline Pharmaceuticals Limited Delivers Sustained Profitability for Quarter Ended June 30, 2025; Continues to Invest in Key Portfolios
GSK India’s CSR Story
Watch GSK India’s CSR Story on NDTV Changemakers
Learn how we are empowering communities across India and driving real impact.
Annual Report 2024-25
Ahead Together with India
With over a century of experience in India, we are moving forward with renewed optimism and confidence. This is our 100th Annual Report, marking yet another milestone in our long and eventful journey.
Scroll to explore
Our purpose
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.Our R&D focus is on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.
INFECTIOUS DISEASES
1 in 3
of us will be affected by shingles in our lifetime
ONCOLOGY
~10m
people died from cancer in 2020, making it a leading cause of death
worldwide
Life at GSK in India
How we help people thrive
Careers
Culture
Experienced professionals
Early careers
In the spotlight
MEDIA
Press releases and other resources
Investors
Shareholder information
Responsibility
Responsible business